Sorafenib tosylate inhibits autophagy, proliferation and migration of oral squamous cell carcinoma

[Objective:] To study the effect of Sorafenib tosylate (ST) on autophagy, proliferation and migration of CAL-27 cells in oral squamous cell carcinoma (OSCC). [Methods:] The CAL-27 cells were treated with different concentrations of ST, and their proliferation activity was detected by CCK-8 and cell...

Full description

Saved in:
Bibliographic Details
Main Authors: XIONG Jianzhe, ZHANG Hao, YU Wei
Format: Article
Language:zho
Published: Editorial Office of Journal of Oral and Maxillofacial Surgery 2024-08-01
Series:Kouqiang hemian waike zazhi
Subjects:
Online Access:https://journal06.magtech.org.cn/Jweb_joms/EN/10.12439/kqhm.1005-4979.2024.04.004
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Objective:] To study the effect of Sorafenib tosylate (ST) on autophagy, proliferation and migration of CAL-27 cells in oral squamous cell carcinoma (OSCC). [Methods:] The CAL-27 cells were treated with different concentrations of ST, and their proliferation activity was detected by CCK-8 and cell clone formation assay; the effect of the CAL-27 cells migration was detected by cell wound scratch assay; the expressions of Beclin1, LC3B and PCNA were detected by western blotting. The CAL-27 cells were pretreated with the autophagy activator rapamycin, and the effects of ST on the proliferation, migration and expression of Beclin1, LC3B and PCNA in CAL-27 cells were detected after activation of autophagy. [Results:] Compared with the control group, ST significantly inhibited the proliferation and migration of the CAL-27 cells. ST decreased the expressions of Beclin-1, PCNA and increased the expressions of the cytoplasmic form LC3Ⅰ and the lipid form LC3Ⅱ of LC3B. However, when the CAL-27 cells were pretreated with RA to activate autophagy, the inhibitory effect of ST on proliferation and migration of the CAL-27 cells were weakened, the expressions of Beclin-1 and PCNA were increased, and the expressions of the cytoplasmic form LC3Ⅰ and the lipid form LC3Ⅱ of LC3B were decreased. [Conclusion:] ST may inhibit the proliferation and migration of CAL-27 cells by down-regulating Beclin-1, and inhibiting autophagy. Inhibition of autophagy may be a potential therapeutic strategy for OSCC.
ISSN:1005-4979